Syros Pharmaceuticals, Inc. (SYRS) Operatsion marja

Syros Pharmaceuticals (SYRS) kompaniyasining rasmiy ramzlari

Syros Pharmaceuticals (SYRS) kompaniyasining saraton hujayralarini qayta dasturlashga bo'lgan innovatsion yondashuvi GURU.Markets platformasidagi operatsion samaradorlik dinamikasi 0.00 qiymatiga ega ekanligi bilan bog'liq. Kompaniya hozirda o'z qarzdorligini qayta tuzmoqda va muvaffaqiyatsiz sinovlardan so'ng o'z patentlari uchun xaridorni qidirmoqda. Biroq, aksiyalar narxining kelgusidagi o'sishi tamibarotene uchun 3-bosqich klinik sinovlar natijalari va FDA tasdig'iga bog'liq.

SYRS - Syros Pharmaceuticals Inc. Operatsion marja 04.07.2022 - 29.03.2025 oraligʻida

SYRS (Syros Pharmaceuticals): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Syros Pharmaceuticals Inc., SYRS
Syros Pharmaceuticals, Inc tayyor mahsulotlari

Ishlab chiqarishni CMO ob'ektlariga autsorsing qilish Syros Pharmaceuticals (SYRS) uchun kapital xarajatlarni minimallashtiradi va xarajatlarni boshqarish samaradorligiga bevosita ta'sir qiladi. Ushbu operatsion foyda marjasi operatsion daromadning tushumga nisbati sifatida hisoblanadi, bu esa investorlarga qarz majburiyatlari va soliqlarni hisobga olmagan holda biznesning tijorat daromadliligini baholash imkonini beradi va shu orqali bozorning potentsial pasayishi oldidan konsolidatsiya bosqichlarini aniqlashga yordam beradi.

Asosiy raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|Bluebird Bio - Operatsion foyda normasi|IPA (ImmunoPrecise Antibodies Ltd) - Operatsion marja|Sotuvning operatsion rentabelligi Omega Therapeutics, Inc. OMGA|Operatsion marja OMIC|RGLS (Regulus Therapeutics Inc.) - Operatsion foyda normasi|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik